Although increased levels of fatty acid synthase (FASN) in tumor cells lead to increased secretion of polyunsaturated FAs into the TME, TAMs increase their lipid levels through CD36 uptake of these polyunsaturated FAs. The gene discussed is FASN; the disease is neoplasm.